pharmacy2u limited

Live MatureMegaHealthy

pharmacy2u limited Company Information

Share PHARMACY2U LIMITED

Company Number

03802593

Directors

Gary Dannatt

Philip Day

View All

Shareholders

p2u holdings limited

Group Structure

View All

Industry

Dispensing chemist in specialised stores

 

Registered Address

lumina park approach, thorpe park, leeds, LS15 8GB

pharmacy2u limited Estimated Valuation

£130.8m

Pomanda estimates the enterprise value of PHARMACY2U LIMITED at £130.8m based on a Turnover of £199.3m and 0.66x industry multiple (adjusted for size and gross margin).

pharmacy2u limited Estimated Valuation

£30.1m

Pomanda estimates the enterprise value of PHARMACY2U LIMITED at £30.1m based on an EBITDA of £4m and a 7.52x industry multiple (adjusted for size and gross margin).

pharmacy2u limited Estimated Valuation

£42.5m

Pomanda estimates the enterprise value of PHARMACY2U LIMITED at £42.5m based on Net Assets of £20.3m and 2.09x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Pharmacy2u Limited Overview

Pharmacy2u Limited is a live company located in leeds, LS15 8GB with a Companies House number of 03802593. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in July 1999, it's largest shareholder is p2u holdings limited with a 100% stake. Pharmacy2u Limited is a mature, mega sized company, Pomanda has estimated its turnover at £199.3m with healthy growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Pharmacy2u Limited Health Check

Pomanda's financial health check has awarded Pharmacy2U Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 3 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating4out of 5
positive_score

5 Strong

positive_score

4 Regular

positive_score

3 Weak

size

Size

annual sales of £199.3m, make it larger than the average company (£12.7m)

£199.3m - Pharmacy2u Limited

£12.7m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 13%, show it is growing at a faster rate (7.4%)

13% - Pharmacy2u Limited

7.4% - Industry AVG

production

Production

with a gross margin of 26.1%, this company has a comparable cost of product (31.4%)

26.1% - Pharmacy2u Limited

31.4% - Industry AVG

profitability

Profitability

an operating margin of 1% make it less profitable than the average company (2.5%)

1% - Pharmacy2u Limited

2.5% - Industry AVG

employees

Employees

with 502 employees, this is above the industry average (69)

502 - Pharmacy2u Limited

69 - Industry AVG

paystructure

Pay Structure

on an average salary of £31.7k, the company has an equivalent pay structure (£26.7k)

£31.7k - Pharmacy2u Limited

£26.7k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £397k, this is more efficient (£145.3k)

£397k - Pharmacy2u Limited

£145.3k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 29 days, this is near the average (29 days)

29 days - Pharmacy2u Limited

29 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 86 days, this is slower than average (63 days)

86 days - Pharmacy2u Limited

63 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 26 days, this is in line with average (32 days)

26 days - Pharmacy2u Limited

32 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 2 weeks, this is less cash available to meet short term requirements (13 weeks)

2 weeks - Pharmacy2u Limited

13 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 83.9%, this is a higher level of debt than the average (59%)

83.9% - Pharmacy2u Limited

59% - Industry AVG

PHARMACY2U LIMITED financials

EXPORTms excel logo

Pharmacy2U Limited's latest turnover from March 2024 is £199.3 million and the company has net assets of £20.3 million. According to their latest financial statements, Pharmacy2U Limited has 502 employees and maintains cash reserves of £2.3 million as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Turnover199,281,000173,442,000165,067,000139,824,00078,329,00060,672,00043,168,00025,844,00017,032,00017,545,00017,078,00015,815,00018,634,00019,961,00019,521,000
Other Income Or Grants000000000000000
Cost Of Sales147,288,000128,450,000110,035,000100,050,00058,160,00045,509,00031,736,00017,764,00011,033,00010,778,00010,815,00011,046,00013,406,00014,425,00014,320,000
Gross Profit51,993,00044,992,00055,032,00039,774,00020,169,00015,163,00011,432,0008,080,0005,999,0006,767,0006,263,0004,769,0005,228,0005,536,0005,201,000
Admin Expenses50,025,00049,725,00051,455,00039,028,00026,936,00031,485,00023,638,00028,563,0008,860,0007,676,0006,313,0004,827,0004,883,0004,780,0624,345,427
Operating Profit1,968,000-4,733,0003,577,000746,000-6,767,000-16,322,000-12,206,000-20,483,000-2,861,000-909,000-50,000-58,000345,000755,938855,573
Interest Payable5,372,000911,000656,000620,000469,00075,000269,000158,00063,00012,00000002,000
Interest Receivable0000011,00008,000003,00013,00011,00016,0008,000
Pre-Tax Profit-3,404,000-5,644,0002,921,000126,000-7,236,000-16,386,000-12,475,000-20,633,000-2,924,000-921,000-47,000-45,000356,000762,000850,000
Tax6,122,000459,000274,0002,052,0003,448,000431,000342,000330,000557,000182,00055,00045,000-156,000-213,000-232,000
Profit After Tax2,718,000-5,185,0003,195,0002,178,000-3,788,000-15,955,000-12,133,000-20,303,000-2,367,000-739,0008,0000200,000549,000618,000
Dividends Paid000000000000000
Retained Profit2,718,000-5,185,0003,195,0002,178,000-3,788,000-15,955,000-12,133,000-20,303,000-2,367,000-739,0008,0000200,000549,000618,000
Employee Costs15,921,00015,511,00015,788,00011,430,0009,454,00010,244,0007,634,0004,681,0003,451,0002,646,0002,238,0001,878,0001,867,0001,857,0001,598,000
Number Of Employees502528535400352299218157100785351525247
EBITDA*4,005,000-2,968,0005,265,0001,833,000-5,156,000-14,847,000-10,971,000-19,248,000-2,333,000-628,000276,000203,000502,000901,938989,573

* Earnings Before Interest, Tax, Depreciation and Amortisation

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Tangible Assets76,293,00023,703,00029,694,00026,911,00020,975,0004,517,0003,402,0003,588,0003,724,0001,897,000540,000519,000502,000410,000454,000
Intangible Assets12,826,00011,668,0007,126,0006,224,0005,519,0004,755,0004,764,0004,401,0002,457,0002,221,0002,221,0002,342,000000
Investments & Other45,498,00025,000000616,0001,0001,0001,0001,00000000
Debtors (Due After 1 year)14,562,0007,149,0005,589,0005,525,0003,284,00000000386,000231,000186,000287,0000
Total Fixed Assets89,119,00035,371,00031,231,00027,610,00023,210,0009,272,0008,166,0007,989,0006,181,0004,118,0003,147,0003,092,000688,000697,000454,000
Stock & work in progress10,878,0009,202,0008,516,0006,422,0004,388,0003,092,0001,914,000954,000899,0001,000,000662,000637,000890,0001,068,000667,000
Trade Debtors15,900,00016,106,00014,956,00024,130,00011,779,0008,217,0005,665,0002,962,0001,336,0001,912,0001,465,0001,366,0001,603,0001,961,0001,240,000
Group Debtors001,678,0001,529,0001,573,0001,481,000973,00000000000
Misc Debtors7,918,0005,296,0006,369,0004,857,0003,202,0002,548,0001,986,0001,902,0001,481,000826,000586,000663,000506,000594,0001,228,000
Cash2,290,0002,472,000526,0002,302,0003,245,0009,663,00020,929,000614,000656,000127,000422,0001,253,0002,413,0001,521,0001,104,000
misc current assets000000672,0000000000653,000
total current assets36,986,00033,076,00032,045,00039,240,00025,741,00025,775,00032,139,0006,432,0004,372,0003,865,0003,135,0003,919,0005,412,0005,144,0004,892,000
total assets126,105,00068,447,00063,276,00066,850,00048,951,00035,047,00040,305,00014,421,00010,553,0007,983,0006,282,0007,011,0006,100,0005,841,0005,346,000
Bank overdraft00000001,706,000921,000000000
Bank loan001,182,0001,137,0000202,000240,00000000000
Trade Creditors 34,884,00030,339,00026,015,00023,030,00014,391,00012,126,00010,206,0006,764,0002,686,0003,023,0002,439,0002,416,0002,645,0002,560,0002,742,000
Group/Directors Accounts000000000105,00000000
other short term finances10,210,00012,058,0004,606,0009,907,0006,302,0004,000,0004,000,00000955,00000000
hp & lease commitments811,000775,000538,000547,000371,0000000000004,000
other current liabilities001,869,0004,658,0001,569,0001,122,0002,060,000925,000491,000372,000484,0001,272,000385,000443,000284,000
total current liabilities45,905,00043,172,00034,210,00039,279,00022,633,00017,450,00016,506,0009,395,0004,098,0004,455,0002,923,0003,688,0003,030,0003,003,0003,030,000
loans119,630,00015,126,0009,702,00013,140,00016,036,000214,000620,0003,900,0001,560,000876,00000000
hp & lease commitments3,256,0004,067,0004,548,0005,085,0005,633,0000000000000
Accruals and Deferred Income00000000405,000000000
other liabilities45,00090,000135,000180,000225,0000000450,00000000
provisions001,264,0001,136,00000000000000
total long term liabilities59,860,0007,653,0005,618,0007,318,0008,243,000107,000310,0001,950,0001,185,000888,00000000
total liabilities105,765,00050,825,00039,828,00046,597,00030,876,00017,557,00016,816,00011,345,0005,283,0005,343,0002,923,0003,688,0003,030,0003,003,0003,030,000
net assets20,340,00017,622,00023,448,00020,253,00018,075,00017,490,00023,489,0003,076,0005,270,0002,640,0003,359,0003,323,0003,070,0002,838,0002,316,000
total shareholders funds20,340,00017,622,00023,448,00020,253,00018,075,00017,490,00023,489,0003,076,0005,270,0002,640,0003,359,0003,323,0003,070,0002,838,0002,316,000
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Operating Activities
Operating Profit1,968,000-4,733,0003,577,000746,000-6,767,000-16,322,000-12,206,000-20,483,000-2,861,000-909,000-50,000-58,000345,000755,938855,573
Depreciation1,523,0001,251,0001,126,000702,000792,000765,000684,000684,000528,000281,000205,000183,000157,000146,000134,000
Amortisation514,000514,000562,000385,000819,000710,000551,000551,00000121,00078,000000
Tax6,122,000459,000274,0002,052,0003,448,000431,000342,000330,000557,000182,00055,00045,000-156,000-213,000-232,000
Stock1,676,000686,0002,094,0002,034,0001,296,0001,178,000960,00055,000-101,000338,00025,000-253,000-178,000401,000667,000
Debtors9,829,000-41,000-7,449,00016,203,0007,592,0003,622,0003,760,0002,047,00079,000301,000177,000-35,000-547,000374,0002,468,000
Creditors4,545,0004,324,0002,985,0008,639,0002,265,0001,920,0003,442,0004,078,000-337,000584,00023,000-229,00085,000-182,0002,742,000
Accruals and Deferred Income0-1,869,000-2,789,0003,089,000447,000-938,0001,135,00029,000524,000-112,000-788,000887,000-58,000159,000284,000
Deferred Taxes & Provisions0-1,264,000128,0001,136,00000000000000
Cash flow from operations3,167,000-1,963,00011,218,000-1,488,000-7,884,000-18,234,000-10,772,000-16,913,000-1,567,000-613,000-636,0001,194,0001,098,000-109,062648,573
Investing Activities
capital expenditure-55,785,000-316,000-5,373,000-7,728,000-18,833,000-2,581,000-1,412,000-3,043,000-2,591,000-1,638,000-227,000-199,000-252,000-127,000-221,000
Change in Investments45,473,00025,00000-616,000615,0000001,00000000
cash flow from investments-101,258,000-341,000-5,373,000-7,728,000-18,217,000-3,196,000-1,412,000-3,043,000-2,591,000-1,639,000-227,000-199,000-252,000-127,000-221,000
Financing Activities
Bank loans0-1,182,00045,0001,137,000-202,000-38,000240,00000000000
Group/Directors Accounts00000000-105,000105,00000000
Other Short Term Loans -1,848,0007,452,000-5,301,0003,605,0002,302,00004,000,0000-955,000955,00000000
Long term loans104,504,0005,424,000-3,438,000-2,896,00015,822,000-406,000-3,280,0002,340,000684,000876,00000000
Hire Purchase and Lease Commitments-775,000-244,000-546,000-372,0006,004,00000000000-4,0004,000
other long term liabilities-45,000-45,000-45,000-45,000225,000000-450,000450,00000000
share issue0-641,000004,373,0009,956,00032,546,00018,109,0004,997,00020,00028,000253,00032,000-27,0001,698,000
interest-5,372,000-911,000-656,000-620,000-469,000-64,000-269,000-150,000-63,000-12,0003,00013,00011,00016,0006,000
cash flow from financing96,464,0009,853,000-9,941,000809,00028,055,0009,448,00033,237,00020,299,0004,108,0002,394,00031,000266,00043,000-15,0001,708,000
cash and cash equivalents
cash-182,0001,946,000-1,776,000-943,000-6,418,000-11,266,00020,315,000-42,000529,000-295,000-831,000-1,160,000892,000417,0001,104,000
overdraft000000-1,706,000785,000921,000000000
change in cash-182,0001,946,000-1,776,000-943,000-6,418,000-11,266,00022,021,000-827,000-392,000-295,000-831,000-1,160,000892,000417,0001,104,000

pharmacy2u limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for pharmacy2u limited. Get real-time insights into pharmacy2u limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Pharmacy2u Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for pharmacy2u limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other mega companies, companies in LS15 area or any other competitors across 12 key performance metrics.

pharmacy2u limited Ownership

PHARMACY2U LIMITED group structure

Pharmacy2U Limited has 4 subsidiary companies.

PHARMACY2U LIMITED Shareholders

p2u holdings limited 100%

pharmacy2u limited directors

Pharmacy2U Limited currently has 4 directors. The longest serving directors include Mr Gary Dannatt (Jul 2016) and Mr Philip Day (Jun 2019).

officercountryagestartendrole
Mr Gary Dannatt53 years Jul 2016- Director
Mr Philip DayEngland51 years Jun 2019- Director
Mr Kevin HeathEngland49 years Dec 2022- Director
Mr Scott FawcettEngland47 years Feb 2023- Director

P&L

March 2024

turnover

199.3m

+15%

operating profit

2m

-142%

gross margin

26.1%

+0.58%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2024

net assets

20.3m

+0.15%

total assets

126.1m

+0.84%

cash

2.3m

-0.07%

net assets

Total assets minus all liabilities

pharmacy2u limited company details

company number

03802593

Type

Private limited with Share Capital

industry

47730 - Dispensing chemist in specialised stores

incorporation date

July 1999

age

26

incorporated

UK

ultimate parent company

accounts

Full Accounts

last accounts submitted

March 2024

previous names

pharmacy 2u limited (March 2010)

accountant

-

auditor

BDO LLP

address

lumina park approach, thorpe park, leeds, LS15 8GB

Bank

BARCLAYS BANK PLC

Legal Advisor

SQUIRE PATTON BOGGS (UK) LLP

pharmacy2u limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 11 charges/mortgages relating to pharmacy2u limited. Currently there are 4 open charges and 7 have been satisfied in the past.

pharmacy2u limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for PHARMACY2U LIMITED. This can take several minutes, an email will notify you when this has completed.

pharmacy2u limited Companies House Filings - See Documents

datedescriptionview/download